Tetrindole

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Tetrindole
Tetrindole skeletal.svg
Tetrindole ball-and-stick.png
Systematic (IUPAC) name
2,3,3a,4,5,6-Hexahydro-8-cyclohexyl-1H-pyrazino[3,2,1-j,k]carbazole
Clinical data
Legal status
?
Identifiers
CAS number  YesY
ATC code None
PubChem CID 160020
ChemSpider 140675 YesY
ChEBI CHEBI:77799 N
Chemical data
Formula C20H26N2 
Mol. mass 294.43 g/mol
 N (what is this?)  (verify)

Tetrindole is a drug candidate that functions by inhibiting monoamine oxidase A; it was first synthesized in Moscow in the early 1990s.[1] Tetrindole is similar in its chemical structure to pirazidol, pirlindole, and metralindole.[2]

References[edit]

  1. ^ Medvedev, Alexei E.; Alexandra A. Kirkel, Natalia S. Kamyshanskaya, Tatyana A. Moskvitina, Ludmila N. Axenova, Vladimir Z. Gorkin, Natalia I. Andreeva, Svetlana M. Golovina and Mikhail D. Mashkovsky (20 January 1994). "Monoamine oxidase inhibition by novel antidepressant tetrindole". Biochemical Pharmacology 47 (2): 303–308. doi:10.1016/0006-2952(94)90021-3. PMID 8304974. 
  2. ^ Ramsay RR, Gravestock MB. Monoamine oxidases: to inhibit or not to inhibit. Mini Rev Med Chem. 2003 Mar;3(2):129-36. PMID 12570845